Exercise Preferences in Young Adults with Cancer-The YOUEX Study

Curr Oncol. 2023 Jan 21;30(2):1473-1487. doi: 10.3390/curroncol30020113.

Abstract

(1) Background: Strong evidence supports the persuasive positive effects of exercise for cancer patients and survivors. Different approaches of exercise programs have been established; however, the special interests of young adults (YAs) with cancer have rarely been considered in exercise interventions. Therefore, the study YOUng EXercisers (YOUEX) aimed to investigate exercise preferences in YAs. (2) Methods: YOUEX was a three-arm, patient preference-based non-randomized, longitudinal, pre-post exercise intervention, offering three different exercise modules to YAs during or after acute therapy (Module 1: online supervised group-based (M1); Module 2: online unsupervised (M2); Module 3: in-person supervised (M3)). The intervention period was 12 weeks with another 12-week follow-up period, the modules could be changed or amended after 6 and 12 weeks. (3) Results: 92 YAs were allocated to the study. At baseline, 50 YAs (54%) chose M2, 32 YAs (35%) M1 and 10 YAs (11%) M3. The analysis revealed high acceptability and feasibility of the online exercise programs (M1, M2). There was a high impact of the COVID-19 pandemic on the execution of M3. YAs showed diverse preferences in module selection due to differences in, e.g., cancer therapy status or favored level of supervision. (4) Conclusions: YAs need personalized exercise programs that consider their individual interests and needs. Online exercise programs can be a promising addition to existing exercise opportunities. They are an effective way to increase physical activity levels in YAs.

Trial registration: ClinicalTrials.gov NCT05613699.

Keywords: COVID-19; adolescents and young adults (AYA); breast cancer; exercise; oncology; online exercise programs; physical activity.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19*
  • Exercise
  • Exercise Therapy
  • Humans
  • Neoplasms* / therapy
  • Pandemics
  • Young Adult

Associated data

  • ClinicalTrials.gov/NCT05613699

Grants and funding

This research was funded by the German Foundation of Young Adults with Cancer, grant number 17/10/2022.